RecruitingNCT06223880
AXS-05 or bupropion to prevent return of depressive symptoms
About this title
Read the official source — NCT06223880Medication studyAges 18–65United StatesDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Bellflower and 39 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 27, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 350
- Sponsor
- Axsome Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06223880
- Official title
Show the full official title
A Randomized, Double-blind, Active-controlled Study of AXS-05 for the Prevention of Relapse of Depressive Symptoms
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Bellflower · Lafayette · Oceanside
34 more locations
- Redlands
- Riverside
- San Diego
- Upland
- Brandon
- Doral
- Hialeah
- Jacksonville
- Miami
- Orlando
- Atlanta
- Chicago
- Overland Park
- New Orleans
- Boston
- Saint Charles
- Las Vegas
- Cherry Hill
- Toms River
- Brooklyn
- Mount Kisco
- New York
- Staten Island
- Hickory
- Cincinnati
- Edmond
- Oklahoma City
- Portland
- Memphis
- Dallas
- Friendswood
- San Antonio
- Wichita Falls
- Everett
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Axsome Therapeutics, Inc.
Does this study involve medication?
Yes. The study involves medication, including AXS-05 and Bupropion.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
